Articles

Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients

Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Department of Pediatric Oncology, Erasmus MC-Sophia Children’s Hospital, Erasmus University Medical Center, Rotterdam, the Netherlands
Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands;Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Research Institute Children’s Cancer Center and Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Research Institute Children’s Cancer Center and Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Dutch Childhood Oncology Group, The Hague, the Netherlands
Australian and New Zealand Children’s Oncology Group, Children’s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia
Australian and New Zealand Children’s Oncology Group, Children’s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia
Oncology Unit, The Children’s Hospital at Westmead, Sydney, Australia
Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands;Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Department of Pediatric Oncology, Erasmus MC-Sophia Children’s Hospital, Erasmus University Medical Center, Rotterdam, the Netherlands
Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, the Netherlands
Vol. 102 No. 3 (2017): March, 2017 https://doi.org/10.3324/haematol.2016.153023